For Immediate Release August 18, 2021 Contact: Elizabeth Goodsitt/Jennifer Miller 608-266-1683 Wisconsin to Offer Additional COVID-19 Vaccine Dose to People Who Are Immunocompromised DHS supports FDA, ACIP recommendations of additional dose of mRNA vaccine to people who are moderately to severely immunocompromised The Wisconsin Department of Health Services (DHS) supports the recommendation that some immunocompromised people are recommended and eligible to get an additional dose of Pfizer (ages 12 and up) or Moderna (ages 18 and up) COVID-19 vaccine following a completed series. "Our nation's leading medical experts have reviewed the available data and made this recommendation to improve protection against COVID-19 for some of our most vulnerable populations," said DHS Secretary-designee Karen Timberlake. "Clinical experts reviewing data from the first months of administering COVID-19 vaccines have determined that certain medical conditions and treatments keep people from building the full immunity we would expect from the original two-dose mRNA vaccine series." After rigorous review of all available data, the U.S. Food and Drug Administration (FDA) authorized the additional dose for certain immunocompromised people on Thursday. On Friday, August 13, the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend an additional dose for individuals with specific medical conditions or who are receiving treatments that are associated with moderate to severe immune compromise. View the entire news release. |
No comments:
Post a Comment